EVAN CHASTAIN: Open Payments
NPI 1427291509 · WINTER GARDEN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,175 in 56 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,175
Food & beverage: $1,175
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 11 | $272 |
| Lilly USA, LLC | 7 | $153 |
| Regeneron Healthcare Solutions, Inc. | 8 | $143 |
| GENZYME CORPORATION | 4 | $105 |
| Janssen Biotech, Inc. | 3 | $85 |
| E.R. Squibb & Sons, L.L.C. | 4 | $78 |
| Novartis Pharmaceuticals Corporation | 4 | $70 |
| Botanix SB Inc | 3 | $61 |
| Arcutis Biotherapeutics, Inc. | 3 | $56 |
| Amgen Inc. | 3 | $45 |
Products named: Bimzelx, DUPIXENT, EBGLYSS, TREMFYA, Sotyktu, SOFDRA, COSENTYX, Zoryve.
Industry payments across FL — which companies pay providers there.
